Poly Medicure Limited has announced the update and re-issuance of five significant corporate policies by its Board of Directors on November 05, 2026. These policies include the ‘Policy for determining Material Subsidiary’, ‘Policy for Determination of Materiality of Events or Information’, ‘Policy on Related Party Transactions’, ‘Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information’, and ‘Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons’. These updates are effective from November 05, 2026 and aim to enhance transparency, governance, and compliance with regulatory requirements.
Key Policy Updates Announced
Poly Medicure Limited has officially updated and re-issued five critical policies following a meeting of its Board of Directors held on November 05, 2026. These revisions are effective from the same date, November 05, 2026.
Revised Policies and Their Scope
The updated policies aim to ensure robust corporate governance, fair disclosure practices, and stringent insider trading regulations. The key policies that have been revised and re-issued are:
- Policy for determining Material Subsidiary (Annexure – I)
- Policy for Determination of Materiality of Events or Information (Annexure – II)
- Policy on Related Party Transactions (Annexure – III)
- Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information (Annexure – IV)
- Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and Their Immediate Relatives (Annexure – V)
The company emphasizes that these updated policies are designed to align with the latest regulatory requirements and to maintain high standards of transparency and fairness in its dealings. The detailed policies are accessible on the company’s website at www.polymedicure.com.
This intimation is provided for information and record purposes to the stock exchanges.
Source: BSE
